Most Clicked StoriesMore >
One-third of new diabetes patients do not get first-line drugs
DiabetesPro SmartBrief | May 25, 2012
A study in the American Journal of Medicine revealed 35% of patients with newly diagnosed type 2 diabetes did not receive the recommended first-line drug. "Pharmacotherapy for diabetes presents a significant opportunity for quality and performance improvement initiatives and holds the potential to realize significant savings for patients, payers, and the entire health care system," a study author said. Modern Medicine (05/24)
High vitamin D levels curb mortality in metabolic syndrome patients
DiabetesPro SmartBrief | May 24, 2012
CDC: Fewer diabetes patients die of heart disease, stroke
DiabetesPro SmartBrief | May 23, 2012
Study looks at misdiagnosed latent autoimmune diabetes in adults
DiabetesPro SmartBrief | May 29, 2012
Diabetes drug DiaPep277 obtains orphan status
DiabetesPro SmartBrief | May 24, 2012
Dulaglutide shows blood glucose benefits in midstage trial
DiabetesPro SmartBrief | May 23, 2012
Obese patients might benefit from liraglutide treatment
DiabetesPro SmartBrief | May 24, 2012
Better diabetes care seen with telemedicine use
DiabetesPro SmartBrief | May 25, 2012
Study: Linagliptin improves A1C in blacks with diabetes
DiabetesPro SmartBrief | May 25, 2012
Experts create color-changing contact lenses for diabetes
DiabetesPro SmartBrief | May 25, 2012
Find DiabetesPro SmartBrief Issues by Date:
ADA News
More >
Diabetes is Primary – CME Program and Performance Improvement Study
DiabetesPro SmartBrief | May 29, 2012
Diabetes Risk Test Brochures - Bilingual (50/Pkg)
DiabetesPro SmartBrief | May 29, 2012
Free resource from the American Diabetes Association
DiabetesPro SmartBrief | May 25, 2012
Access more than 12,000 health care resources now!
DiabetesPro SmartBrief | May 24, 2012
Free webcasts from the 59th Annual Postgraduate Course - Now available with CME/CE credits!
DiabetesPro SmartBrief | May 22, 2012
Sign up for DiabetesPro SmartBrief
Recent Poll view more polls